360 related articles for article (PubMed ID: 21732757)
1. Organ-specific markers in circulating tumor cell screening: an early indicator of metastasis-capable malignancy.
Paterlini-Bréchot P
Future Oncol; 2011 Jul; 7(7):849-71. PubMed ID: 21732757
[TBL] [Abstract][Full Text] [Related]
2. Circulating tumor cells as promising novel biomarkers in solid cancers.
Lianidou ES; Strati A; Markou A
Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
[TBL] [Abstract][Full Text] [Related]
3. Isolation of rare circulating tumor cells in cancer patients: technical aspects and clinical implications.
Danova M; Torchio M; Mazzini G
Expert Rev Mol Diagn; 2011 Jun; 11(5):473-85. PubMed ID: 21707456
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells: a multifunctional biomarker.
Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
[TBL] [Abstract][Full Text] [Related]
5. Relevance of molecular characterization of circulating tumor cells in breast cancer in the era of targeted therapies.
Nadal R; Lorente JA; Rosell R; Serrano MJ
Expert Rev Mol Diagn; 2013 Apr; 13(3):295-307. PubMed ID: 23570407
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cells as therapy-related biomarkers in cancer patients.
Gorges TM; Pantel K
Cancer Immunol Immunother; 2013 May; 62(5):931-9. PubMed ID: 23314304
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
[TBL] [Abstract][Full Text] [Related]
8. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients.
Yoon SO; Kim YT; Jung KC; Jeon YK; Kim BH; Kim CW
Lung Cancer; 2011 Feb; 71(2):209-16. PubMed ID: 20471712
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells in colorectal cancer patients.
Torino F; Bonmassar E; Bonmassar L; De Vecchis L; Barnabei A; Zuppi C; Capoluongo E; Aquino A
Cancer Treat Rev; 2013 Nov; 39(7):759-72. PubMed ID: 23375250
[TBL] [Abstract][Full Text] [Related]
10. Current challenges in metastasis: disseminated and circulating tumor cells detection.
Shahneh FZ
Hum Antibodies; 2013; 22(3-4):77-85. PubMed ID: 24961866
[TBL] [Abstract][Full Text] [Related]
11. The clinical significance of circulating tumor cells in the peripheral blood.
Elshimali YI; Grody WW
Diagn Mol Pathol; 2006 Dec; 15(4):187-94. PubMed ID: 17122646
[TBL] [Abstract][Full Text] [Related]
12. CTC clusters in cancer progression and metastasis.
Fabisiewicz A; Grzybowska E
Med Oncol; 2017 Jan; 34(1):12. PubMed ID: 28012133
[TBL] [Abstract][Full Text] [Related]
13. Overview of current standpoints in profiling of circulating tumor cells.
Kim K; Lee KH; Lee J; Choi J
Arch Pharm Res; 2014 Jan; 37(1):88-95. PubMed ID: 24214218
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of circulating tumor cells in breast cancer patients.
Tao M; Ma D; Li Y; Zhou C; Li Y; Zhang Y; Duan W; Xu X; Wang R; Wu L; Liu H
Breast Cancer Res Treat; 2011 Aug; 129(1):247-54. PubMed ID: 21512769
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor cells as a predictive biomarker in patients with hormone-sensitive prostate cancer.
Goodman OB; Symanowski JT; Loudyi A; Fink LM; Ward DC; Vogelzang NJ
Clin Genitourin Cancer; 2011 Sep; 9(1):31-8. PubMed ID: 21705286
[TBL] [Abstract][Full Text] [Related]
16. Global gene expression profiling of circulating tumor cells.
Smirnov DA; Zweitzig DR; Foulk BW; Miller MC; Doyle GV; Pienta KJ; Meropol NJ; Weiner LM; Cohen SJ; Moreno JG; Connelly MC; Terstappen LW; O'Hara SM
Cancer Res; 2005 Jun; 65(12):4993-7. PubMed ID: 15958538
[TBL] [Abstract][Full Text] [Related]
17. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
[TBL] [Abstract][Full Text] [Related]
18. Biologic challenges in the detection of circulating tumor cells.
Joosse SA; Pantel K
Cancer Res; 2013 Jan; 73(1):8-11. PubMed ID: 23271724
[TBL] [Abstract][Full Text] [Related]
19. Essentials of circulating tumor cells for clinical research and practice.
Liberko M; Kolostova K; Bobek V
Crit Rev Oncol Hematol; 2013 Nov; 88(2):338-56. PubMed ID: 23830807
[TBL] [Abstract][Full Text] [Related]
20. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
